These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 18949510)

  • 41. Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy.
    Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
    Gut; 2014 May; 63(5):720-6. PubMed ID: 23831734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Clinical Efficacy of a Pure Alginate Formulation (Lamina G) for Controlling Symptoms in Individuals with Reflux Symptoms: A Randomized Clinical Study.
    Kim JH; Lee YC; Kim EH; Park JC; Shin SK; Lee SK; Jung DH; Park JJ; Youn YH; Park H
    Gut Liver; 2019 Nov; 13(6):642-648. PubMed ID: 30970442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gastroesophageal Reflux Disease: Pathophysiology, Diagnosis, and Treatment.
    Chen J; Brady P
    Gastroenterol Nurs; 2019; 42(1):20-28. PubMed ID: 30688703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of gastroesophageal reflux symptoms in a large unselected general population in Japan.
    Yamagishi H; Koike T; Ohara S; Kobayashi S; Ariizumi K; Abe Y; Iijima K; Imatani A; Inomata Y; Kato K; Shibuya D; Aida S; Shimosegawa T
    World J Gastroenterol; 2008 Mar; 14(9):1358-64. PubMed ID: 18322948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and characteristics of acid gastro-oesophageal reflux disease in Jackhammer oesophagus.
    Mallet AL; Ropert A; Bouguen G; Siproudhis L; Boutroux D; Bretagne JF; Brochard C
    Dig Liver Dis; 2016 Oct; 48(10):1136-41. PubMed ID: 27453169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Esophageal hypermotility: cause or effect?
    Crespin OM; Tatum RP; Yates RB; Sahin M; Coskun K; Martin AV; Wright A; Oelschlager BK; Pellegrini CA
    Dis Esophagus; 2016 Jul; 29(5):497-502. PubMed ID: 25893778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.
    Cadiot G; Delaage PH; Fabry C; Soufflet C; Barthélemy P
    Dig Liver Dis; 2011 Oct; 43(10):784-7. PubMed ID: 21752736
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms.
    Delshad SD; Almario CV; Chey WD; Spiegel BMR
    Gastroenterology; 2020 Apr; 158(5):1250-1261.e2. PubMed ID: 31866243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Heartburn: you can choose to support in the short term].
    Camain JY; Wiesel PH; Peytremann-Bridevaux I
    Rev Med Suisse; 2011 May; 7(296):1169. PubMed ID: 21721208
    [No Abstract]   [Full Text] [Related]  

  • 51. Exacerbation of gastroesophageal reflux symptoms after discontinuation of proton pump inhibitors is not associated with increased esophageal acid exposure.
    Hoshikawa Y; Nikaki K; Sonmez S; Nakagawa K; Yazaki E; Sifrim D; Woodland P
    Neurogastroenterol Motil; 2020 Jan; 32(1):e13735. PubMed ID: 31657519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapy of gastroesophageal reflux disease (GERD)].
    Storr M
    Med Monatsschr Pharm; 2011 Dec; 34(12):446-54; quiz 455-6. PubMed ID: 22233024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM; McIntyre L; Bernard L; Fendrick AM
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical value of random esophageal biopsies in patients with dysphagia and normal endoscopy who are treated with a proton pump inhibitor.
    Kamionkowski S; Shibli F; Saleh S; Trujillo S; Mengalle E; El Mokahal A; Thomas C; Song G; Fass R
    Dis Esophagus; 2024 Apr; 37(4):. PubMed ID: 38197434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease.
    Gerson LB; Fass R
    Clin Gastroenterol Hepatol; 2009 Apr; 7(4):372-8; quiz 367. PubMed ID: 19111949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Multicenter study of gastroesophageal reflux disease symptoms prevalence in outpatients in Russia].
    Bordin DS; Abdulkhakov RА; Osipenko MF; Solovyeva AV; Abdulkhakov SR; Kirilenko NP; Butov MA; Berezina OI; Valitova ER; Safina DD; Alieva IM; Livzan MA; Sarsenbaeva AS; Tarasova GN; Embutnieks YV; Mubarakshina IR; Khayrullin IK; Kononova AG; Kolbasnikov SV; Maev IV
    Ter Arkh; 2022 Jan; 94(1):48-56. PubMed ID: 36286919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of non-obstructive dysphagia in patients with heartburn and regurgitation.
    Batista AO; Nascimento WV; Cassiani RA; Silva ACV; Alves LMT; Alves DC; Dantas RO
    Clinics (Sao Paulo); 2020; 75():e1556. PubMed ID: 31994617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease.
    Thomson RM; Armstrong JG; Looke DF
    Chest; 2007 Apr; 131(4):1166-72. PubMed ID: 17426224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence-based treatment of frequent heartburn: the benefits and limitations of over-the-counter medications.
    McRorie JW; Gibb RD; Miner PB
    J Am Assoc Nurse Pract; 2014 Jun; 26(6):330-9. PubMed ID: 24825071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective Study of Gastroesophageal Reflux, Use of Proton Pump Inhibitors and H2-Receptor Antagonists, and Risk of Hearing Loss.
    Lin BM; Curhan SG; Wang M; Jacobson BC; Eavey R; Stankovic KM; Curhan GC
    Ear Hear; 2017; 38(1):21-27. PubMed ID: 27556519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.